Loading

Slzii.com Search

Search (News)

Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study

Telix Completes Patient Enrollment in TLX591-Px (Illuccix®) Japan Phase 3 Study
Pr Newswire Apac english technology business

Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. The study data will be used to support a New Drug Application (NDA) for TLX591-Px in Japan. MELBOURNE, Australia and TOKYO, July 17, 2026 /PRNewswire/ -- Telix...
2026-07-16 22:00:00

What are you doing?
0.029651880264282


News
News

Latest News and Headlines
Completed enrollment of 105 patients in Phase 3 registration study of TLX591-Px (Illuccix®) for prostate cancer imaging in Japan. The study ...
News